Federal Register of Legislation - Australian Government

Primary content

PB 95 of 2021 Determinations/Health as made
This instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 to allow the substitution of Zumenon (estradiol) in place of Progynova (estradiol valerate).
Administered by: Health
Registered 19 Aug 2021
Tabling HistoryDate
Tabled HR23-Aug-2021
Tabled Senate23-Aug-2021
Date of repeal 26 Nov 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003